By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted March 4, 2024APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS ON MARCH 21, 2024 READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, RenuvionPosted February 21, 2024APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) SCIENTIFIC MEETING READ MORE
By apyxmedical In 2024 Shareholder News, J-Plasma, RenuvionPosted January 22, 2024APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY READ MORE
By Nick Johnson (Apyx) In 2024 Shareholder News, J-Plasma, RenuvionPosted January 8, 2024APYX MEDICAL CORPORATION REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2023 REVENUE RESULTS READ MORE
By Nick Johnson (Apyx) In 2023 Shareholder News, J-Plasma, RenuvionPosted November 28, 2023APYX MEDICAL CORPORATION APPOINTS MATTHEW HILL AS CHIEF FINANCIAL OFFICER READ MORE
By Nick Johnson (Apyx) In 2023 Shareholder News, J-Plasma, RenuvionPosted November 9, 2023APYX MEDICAL CORPORATION ANNOUNCES NEW DEBT FACILITY WITH PERCEPTIVE ADVISORS READ MORE
By Nick Johnson (Apyx) In 2023 Shareholder News, J-Plasma, RenuvionPosted November 9, 2023APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND UPDATES FULL YEAR 2023 FINANCIAL OUTLOOK READ MORE
By Nick Johnson (Apyx) In 2023 Shareholder News, RenuvionPosted November 7, 2023APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted October 2, 2023APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON NOVEMBER 9, 2023 READ MORE
By apyxmedical In 2023 Shareholder News, J-Plasma, RenuvionPosted August 10, 2023APYX MEDICAL CORPORATION REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND REAFFIRMS FULL YEAR 2023 FINANCIAL OUTLOOK READ MORE